Smoking Cessation Clinical Trials Database - Free Access to 523 Studies
Access comprehensive clinical trial information for Smoking Cessation through Pure Global AI's free database. This collection includes 523 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 68 trials are actively recruiting participants.
Research for Smoking Cessation is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include The University of Hong Kong and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia
Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients
Tobacco Education and Lung Health Study (TEAL)
Video Messages for Smoking Cessation Campaign
Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases
Development of Typology-based Smoking Relapse Prevention: A Q-methodology and a Pilot Randomized Controlled Trial
Rural COPD E-Visit Study
Stop Smoking in Spine Surgery
Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Health Staff
Quit Smoking Text Message Study
Quit Smoking: Optimizing Health Promotion Strategy
Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers
Quitxt Mobile Text Messaging Cessation Research Study
Untitled Trial
Testing the Integrated mHealth App Intervention SiS-H
Quit & Fit 2.0: Feasibility and Usability Testing
Impact of E-cigarette Nicotine Concentration on Compensation
Training Secondary School Students as Anti-smoke Ambassadors Using the Service-learning Model
Effectiveness of Different THR Products in Adult Population
Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments
Pure Global AI provides free access to 523 clinical trials studying Smoking Cessation, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include The University of Hong Kong, Pfizer, Yale University, among others.